1. Home
  2. MPTI vs SAVA Comparison

MPTI vs SAVA Comparison

Compare MPTI & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$66.08

Market Cap

189.7M

Sector

N/A

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.30

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
SAVA
Founded
1965
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
96.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MPTI
SAVA
Price
$66.08
$2.30
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
22.5K
601.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.72
N/A
Revenue
$49,012,000.00
N/A
Revenue This Year
$13.32
N/A
Revenue Next Year
$10.56
N/A
P/E Ratio
$36.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.22
$1.15
52 Week High
$68.50
$4.98

Technical Indicators

Market Signals
Indicator
MPTI
SAVA
Relative Strength Index (RSI) 56.96 55.13
Support Level $60.65 $2.01
Resistance Level $67.09 $2.31
Average True Range (ATR) 2.85 0.14
MACD -0.08 0.04
Stochastic Oscillator 69.75 59.59

Price Performance

Historical Comparison
MPTI
SAVA

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: